Use of fused heterocyclic compounds as SCCE inhibitors for the treatment of skin conditions or cancer

Details for Australian Patent Application No. 2004244704 (hide)

Owner Arexis AB

Inventors Linschoten, Marcel

Agent Davies Collison Cave

Pub. Number AU-B-2004244704

PCT Pub. Number WO2004/108139

Priority PA 2003 00842 06.06.03 DK; PA 2003 00840 06.06.03 DK; PA 2003 00843 06.06.03 DK; PA 2003 00844 06.06.03 DK

Filing date 7 June 2004

Wipo publication date 16 December 2004

Acceptance publication date 11 February 2010

International Classifications

A61K 31/536 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems

A61K 31/5365 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/04 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 17/10 (2006.01) Drugs for dermatological disorders

A61P 17/12 (2006.01) Drugs for dermatological disorders

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2004/108139 Priority application(s): WO2004/108139

11 February 2010 Application Accepted

  Published as AU-B-2004244704

10 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004244713-Method and device for the quantitative analysis of solutions and dispersions using near infra-red spectroscopy

2004244701-Cells used as carriers for bacteria